JPRN-UMIN000044546招募中未知
Stereotactic ablative radiation against metastatic lesion detected by DWIBS for High risk Prostate Cancer - STARCAP
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 25years-old 至 80years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) History of any prostate cancer therapy 2) Severe heart disease (NYHA criteria>=class 3) 3) Cerebral vascular disease with higher cerebral dysfunction 4) Liver disease (total bilirubin> 3*ULN OR ALT/AST>5* ULN) 5) Uncontrollable diabetes mellitus (HbA1c >8.0%) 6) Contraindication for MRI 7) Patient who is considered ineligible for enrolling the study by a principal investigator or sub-investigator
研究者
相似试验
招募中
2 期
Stereotactic Radiotherapy for Metastasis to the Lunglung malignancy100386661002910710038737lung cancerNL-OMON35375Erasmus MC, Universitair Medisch Centrum Rotterdam30
已完成
2 期
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): A Randomized Phase II Trialcancer spread to other parts of the bodymetastatic cancer10027476NL-OMON37922Vrije Universiteit Medisch Centrum20
尚未招募
不适用
Mapping guided Stereotactic ablative RadiotherapyNL-OMON27436Departments of Cardiology and Radiotherapy, Leiden University Medical Center12
招募中
不适用
Mapping guided Stereotactic ablative Radiotherapy, Hybrid treatment for uncontrollable ventricular tachycardiacardiomyopathyNL-OMON52679eids Universitair Medisch Centrum12
已完成
不适用
Stereotactic ablative radiotherapy (SABR) for small lung tumors: retrospective analysis 2009-2010C34C78.0Malignant neoplasm of bronchus and lungSecondary malignant neoplasm of lungDRKS00003864niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde39